Insights into the Worldwide C-Met Mutated Non-small Cell Lung Cancer Industry to 2030 - Key Growth Opportunities

Source :: Plus Company Updates. May 15, 2020
Publication Year :: 2020
Abstract: Dublin: Research and Markets has issued the following press release: -The 'Cellular-Mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC)- Epidemiology Forecast to 2030' report has been added [...]

Subjects :: Small cell lung cancer -- Forecasts and trends -- Reports
Epidemiology -- Reports -- Forecasts and trends
Non-small cell lung cancer -- Reports -- Forecasts and trends
Stem cells
Lung cancer
Diseases
Market trend/market analysis
General interest
News, opinion and commentary

Tools